Growth Metrics

Orthopediatrics (KIDS) Debt to Equity (2016 - 2026)

Orthopediatrics has reported Debt to Equity over the past 11 years, most recently at $0.3 for Q1 2026.

  • For Q1 2026, Debt to Equity rose 7095.8% year-over-year to $0.3; the TTM value through Mar 2026 reached $0.3, up 7095.8%, while the annual FY2025 figure was $0.29, 42.03% up from the prior year.
  • Debt to Equity for Q1 2026 was $0.3 at Orthopediatrics, up from $0.29 in the prior quarter.
  • Over five years, Debt to Equity peaked at $0.3 in Q1 2026 and troughed at $0.0 in Q4 2022.
  • A 5-year average of $0.1 and a median of $0.03 in 2024 define the central range for Debt to Equity.
  • Biggest five-year swings in Debt to Equity: tumbled 98.44% in 2023 and later surged 51049.56% in 2024.
  • Year by year, Debt to Equity stood at $0.0 in 2022, then rose by 6.01% to $0.0 in 2023, then surged by 51049.56% to $0.21 in 2024, then surged by 42.03% to $0.29 in 2025, then rose by 3.26% to $0.3 in 2026.
  • Business Quant data shows Debt to Equity for KIDS at $0.3 in Q1 2026, $0.29 in Q4 2025, and $0.28 in Q3 2025.